Annual Total Liabilities
$16.45 M
+$4.08 M+32.98%
31 December 2023
Summary:
Jasper Therapeutics annual total liabilities is currently $16.45 million, with the most recent change of +$4.08 million (+32.98%) on 31 December 2023. During the last 3 years, it has fallen by -$42.03 million (-71.87%). JSPR annual total liabilities is now -71.87% below its all-time high of $58.49 million, reached on 31 December 2020.JSPR Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$15.73 M
+$2.11 M+15.52%
30 September 2024
Summary:
Jasper Therapeutics quarterly total liabilities is currently $15.73 million, with the most recent change of +$2.11 million (+15.52%) on 30 September 2024. Over the past year, it has dropped by -$539.00 thousand (-3.31%). JSPR quarterly total liabilities is now -73.10% below its all-time high of $58.49 million, reached on 31 December 2020.JSPR Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JSPR Total Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +33.0% | -3.3% |
| 3 y3 years | -71.9% | -45.0% |
| 5 y5 years | - | - |
JSPR Total Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -71.9% | +33.0% | -45.0% | +36.3% |
| 5 y | 5 years | -71.9% | +33.0% | -73.1% | +36.3% |
| alltime | all time | -71.9% | +33.0% | -73.1% | +36.3% |
Jasper Therapeutics Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $15.73 M(+15.5%) |
| June 2024 | - | $13.62 M(+7.0%) |
| Mar 2024 | - | $12.73 M(-22.6%) |
| Dec 2023 | $16.45 M(+33.0%) | $16.45 M(+1.1%) |
| Sept 2023 | - | $16.27 M(+16.5%) |
| June 2023 | - | $13.96 M(+3.0%) |
| Mar 2023 | - | $13.56 M(+9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $12.37 M(-48.7%) | $12.37 M(+7.2%) |
| Sept 2022 | - | $11.54 M(-0.3%) |
| June 2022 | - | $11.59 M(-6.9%) |
| Mar 2022 | - | $12.44 M(-48.4%) |
| Dec 2021 | $24.14 M(-58.7%) | $24.14 M(-15.6%) |
| Sept 2021 | - | $28.61 M(-51.1%) |
| Dec 2020 | $58.49 M | $58.49 M |
FAQ
- What is Jasper Therapeutics annual total liabilities?
- What is the all time high annual total liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics annual total liabilities year-on-year change?
- What is Jasper Therapeutics quarterly total liabilities?
- What is the all time high quarterly total liabilities for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly total liabilities year-on-year change?
What is Jasper Therapeutics annual total liabilities?
The current annual total liabilities of JSPR is $16.45 M
What is the all time high annual total liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high annual total liabilities is $58.49 M
What is Jasper Therapeutics annual total liabilities year-on-year change?
Over the past year, JSPR annual total liabilities has changed by +$4.08 M (+32.98%)
What is Jasper Therapeutics quarterly total liabilities?
The current quarterly total liabilities of JSPR is $15.73 M
What is the all time high quarterly total liabilities for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly total liabilities is $58.49 M
What is Jasper Therapeutics quarterly total liabilities year-on-year change?
Over the past year, JSPR quarterly total liabilities has changed by -$539.00 K (-3.31%)